Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Kaplan Fox & Kilsheimer & PROCEPT BioRobotics

2 shared events · Importance 3 · Last updated Sep 11, 2026

Importance
3
Shared Events
2
Actions
3
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
74
Regulatory
Kaplan Fox & Kilsheimer: Filed a class action lawsuit against PROCEPT and is notifying investors of the lead plaintiff deadline.
PROCEPT BioRobotics: The central defendant in the securities fraud class action, facing allegations of misleading investors about handpiece sales and inventory practices. The litigation and associated stock declines of over 48% from August 2025 to February 2026 pose significant financial and reputational risks.
Aug 03, 2026 · 140 articles
71
Regulatory
Kaplan Fox & Kilsheimer: Plaintiff law firm involved in the class action, seeking lead plaintiff role.
PROCEPT BioRobotics: Central defendant in the securities fraud class action. The company's stock plummeted over 48% from August 2025 to February 2026 due to revelations of undisclosed discounting and inventory glut, and it now faces significant legal and financial exposure.
Jul 24, 2026 · 303 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Kaplan Fox & Kilsheimer and PROCEPT BioRobotics interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.